Takeda gets Japan's approval for $62 billion Shire purchase
Takeda Pharmaceutical Co Ltd. said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.
The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the United States, Brazil and China.
Read Also: Takeda gets China approval for Whooping 62 Billion Dollar Shire purchase
The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the United States, Brazil and China.
Read Also: Takeda gets China approval for Whooping 62 Billion Dollar Shire purchase
billion Shire purchaseBrazilchinajapan approvalJapan Fair Trade CommissionJapanese companyJapanese firmShire PlcTakedaTakeda Pharmaceutical Co LtdUnited States
Source : ReutersMedical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd